Correlation Between Johnson Johnson and Aryx Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Aryx Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Aryx Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Aryx Therapeutics, you can compare the effects of market volatilities on Johnson Johnson and Aryx Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Aryx Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Aryx Therapeutics.

Diversification Opportunities for Johnson Johnson and Aryx Therapeutics

  Correlation Coefficient

Good diversification

The 3 months correlation between Johnson and Aryx Therapeutics is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Aryx Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aryx Therapeutics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Aryx Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aryx Therapeutics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Aryx Therapeutics go up and down completely randomly.

Pair Corralation between Johnson Johnson and Aryx Therapeutics

Considering the 90-day investment horizon Johnson Johnson is expected to under-perform the Aryx Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Johnson Johnson is 4.96 times less risky than Aryx Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Aryx Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  0.03  in Aryx Therapeutics on May 12, 2022 and sell it today you would earn a total of  0.02  from holding Aryx Therapeutics or generate 66.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Johnson Johnson  vs.  Aryx Therapeutics

 Performance (%) 
Johnson Johnson 
Johnson Performance
0 of 100
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Johnson Johnson is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Johnson Price Channel

Aryx Therapeutics 
Aryx Therapeutics Performance
13 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Aryx Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Aryx Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Aryx Therapeutics Price Channel

Johnson Johnson and Aryx Therapeutics Volatility Contrast

   Predicted Return Density   

Pair Trading with Johnson Johnson and Aryx Therapeutics

The main advantage of trading using opposite Johnson Johnson and Aryx Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Aryx Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aryx Therapeutics will offset losses from the drop in Aryx Therapeutics' long position.
The idea behind Johnson Johnson and Aryx Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm